Xilio Therapeutics Inc (XLO) Stock Price, Quote, News & History

XLONASDAQ
$9.13
0.091%
At close: Sep 17, 5:00 PM EST
$9.13
0.091%
Pre-Market: 3:00 AM EST

Xilio Therapeutics (XLO) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-60.60M
Investing Cash Flow (TTM)
-670.00K
Financing Cash Flow (TTM)
75.78M
Free Cash Flow (TTM)
-61.27M
Capital Expenditure (TTM)
-670.00K
Net Change in Cash (TTM)
14.51M

Analyst Rating and Forecast

12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$69.92M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.02
PB Ratio (TTM)
0.83
Earnings Yield % (TTM)
-3.52%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$10.98

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$136.04M
Debt to Equity
0.09
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$9.13
Volume / Avg.
0 / 28.23K
Day Range
- - -
52 Wk Range
6.47 - 12.74
Market Cap
$60.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
60
Short Interest
7.1%
Days to Cover
39.07

About

Sector
Health Care
Industry
Biotechnology
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology an...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Xilio Therapeutics (XLO) stock?

A

You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xilio Therapeutics (XLO) competitors?

Q

What is the forecast, or price target, for Xilio Therapeutics (XLO) stock?

A

Xilio Therapeutics has a consensus price target of $42.00.

Q

What is the current price for Xilio Therapeutics (XLO)?

A

The stock price for Xilio Therapeutics (NASDAQ: XLO) is $9.13 last updated September 18, 2026 at 4:00 PM EDT.

Q

Does Xilio Therapeutics (XLO) pay a dividend?

A

There are no upcoming dividends for Xilio Therapeutics.

Q

When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?

A

Xilio Therapeutics does not have any upcoming earnings scheduled.

Q

Is Xilio Therapeutics (XLO) going to split?

A

There is no upcoming split for Xilio Therapeutics.

Q

What sector and industry does Xilio Therapeutics (XLO) operate in?

A

Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.